In vitro drug susceptibility of Chlamydia sp. strain TWAR.
AUTOR(ES)
Kuo, C C
RESUMO
The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic concentration tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172146Documentos Relacionados
- Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.
- In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
- Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR.
- Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR.
- Identification of a new group of Chlamydia psittaci strains called TWAR.
